Search the Archive

Medicine: Depression #1038085

CBS Evening News for Thursday, Dec 06, 2012
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Scott Pelley) Report introduced.

(Studio: Jon LaPook) Studies indicating a new class of drugs may help in treating depression reviewed; animation shown of how brain cell communication breaks down; details given of how the new medications target the chemical glutamate instead of serotonin; study results cited. [Patient Jim STAPLES – comments on his illness.] [Yale University Dr. Gerard SANACORA††- says they might produce very rapid antidepressant effects.] [Researcher Dr. Ron BURCH††- says Glyx-13†† has no side effects of schizophrenia.]

Reporter(s):
Pelley, Scott;
LaPook, Jon
Duration:
00:02:30

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.